Pet Products and Services Awards 2026 | 5 Dentist and Consultant to PetLabCo.®, commented: “The success of ProBright® Advanced in reducing one of the most common compounds responsible for bad breath is a testament to its efficacy.” Furthermore, PetLabCo.®’s Probiotic Chew is the world’s first clinically studied probiotic soft chew for dogs, validated in a double-blind, placebo-controlled trial and published in a peer-reviewed scientific journal. PetLabCo.® worked closely with experts to design a prebiotic and probiotic blend to meet the most pressing gut health issues faced by dogs today, and clinical trialling found the product to significantly enhance a balanced inflammatory response in the gut. These breakthrough products have emerged in a rapidly evolving market, as pet owners increasingly – and rightfully – demand the same standard of science and transparency they would expect for human products. PetLabCo.® remains at the forefront of sectoral advancements by leveraging an in-house R&D function and a scientific advisory board comprising some of the most respected voices across veterinary medicine, dentistry, clinical research, nutrition, and canine longevity science. “Our job is to be ahead of the shift, not behind it,” stated Stephanie. “That is why we were among the first in the category to commit to doubleblind, placebo-controlled studies as a matter of course rather than a marketing exercise. And it is why we keep pushing into new territory, with no intention of slowing down.” PetLabCo.®’s approach is crucial in today’s market, a space that has long been overcrowded with unsupported health claims and marketing hyperbole, making it difficult for genuinely science-led brands to cut through the noise. At the same time, pet owners want to do right by their animals but are struggling to navigate the storm of conflicting information and competing claims. The brand’s commitment to commissioning double-blind, placebocontrolled trials, publishing in peer-reviewed scientific journals, holding NASC certification – the gold standard in independent quality and safety – and third-party testing positions PetLabCo.® as a trusted figure in this space. It reframes the customer relationship entirely, not operating as a brand selling to a shopper but as a partner walking alongside them. “Clear guidance, honest content, expert-reviewed resources, and no hyperbole,” said Stephanie. “Just the science, explained in a way that respects the reader.” 2026 is shaping up to be one of PetLabCo.®’s most ambitious years yet, with multiple new products set to launch. This includes the new salmonflavoured Joint Care Chew Advanced, featuring an advanced formulation with carefully selected, superior ingredients forms that set this emerging product far apart from other joint supplements in the pet market. Where many competitors focus solely on one or two pathways, joint degradation is a multi-pathway process. For this reason, PetLabCo.®’s chew has been expertly designed to deliver comprehensive, multi-pathway support in a single formula. Beyond that, PetLabCo.® looks to maintain its frontrunning industry position through a number of innovative, forward-thinking endeavours. The brand looks forward to further clinical studies across the portfolio, continued investment in its in-house R&D programme, and plans to continue widening its scientific advisory capability. Veterinary professionals and pet owners alike can expect to see PetLabCo.® continue leading in the field of evidence-based, scientifically supported supplements for companion animal health. “We have now impacted the lives of over 5.5 million pets worldwide, and we are committed to building on that year after year,” Stephanie concluded. “Every review we have earned represents a household that trusted us to help guide a decision about an animal they love. That trust is the single most important thing we have, and it is exactly why we continue to invest so heavily in clinical research, in ingredient integrity, and in honest, jargon-free communication.” She continued: “We are genuinely proud to have been named LUXlife’s Best Canine Oral Health Supplement Brand for the second consecutive year, and to have received the Science-Led Product Development Excellence Award 2026. Recognition like this tells us the work being done behind the scenes is being seen and valued. But our focus remains exactly where it has always been, on being Your Most Trusted Pet Health Optimisation Partner™.” Contact: Stephanie Lee Company: PetLabCo.® Web Address: www.thepetlabco.com
RkJQdWJsaXNoZXIy MTUyMDQwMA==